OpenAI Acquires Bio Startup Orchestra

OpenAI has acquired Orchestra Bio, a startup building AI agents for pharmaceutical companies, exclusively with Axios. Financial terms were not disclosed. The company will integrate Orchestra's team and technology into Rosalind, its suite of AI models for life sciences researchers.